Rubrik: Aktuelle Epidemiologie und Diagnostik in der Mikrobiologie
Milzbrand: Gestern so, heute so und morgen vielleicht ganz anders (S. 46)
1. Koch R. Untersuchung über die Aetiologie der Wundinfectionskrankheiten. Leipzig, 1878. Staatsbibliothek zu Berlin – Preußischer Kulturbesitz. SBB-PK, Jx 1782<a> R. urn:nbn:de:kobv:b4-200905193237.
2. Doganay M, Dinc G, Kutmanova A, Baillie L. Human anthrax: update of the diagnosis and treatment. Diagnostics (Basel) 2023; 13 (6): 1056. doi: 10.3390/diagnostics13061056.
3. Friesecke I, Biederbick W, Boecken G, Gottschalk R, Koch HU, Peters G, Peters S, Sasse J, Stich A. Biologische Gefahren II - Entscheidungshilfen zu medizinisch angemessenen Vorgehensweisen in einer B-Gefahrenlage. Herausgeber: Bundesamt für Bevölkerungsschutz und Katastrophenhilfe und Robert Koch Institut (2007). https://www.rki.de/DE/Content/Infekt/Biosicherheit/Agenzien/bg_anthrax.pdf
4. Guidelines Review Committee der World Health Organization (WHO). Anthrax in humans and animals. 4. Auflage (2008). ISBN: 9789241547536.
5. Hendricks K, Person MK, Bradley JS, Mongkolrattanothai T, Hupert N, Eichacker P, Friedlander AM, Bower WA. Clinical features of patients hospitalized for all routes of anthrax, 1880-2018: A systematic review. Clin Infect Dis 2022; 75 (Suppl 3): S341-S353. doi: 10.1093/cid/ciac534.
6. Robert Koch Institut (RKI). https://survstat.rki.de/Content/Query/Chart.aspx
7. Kozytska T, Bassiouny M, Chechet O, Ordynska D, Galante D, Neubauer H, Wareth G. Retrospective analysis of official data on Anthrax in Europe with a special reference to Ukraine. Microorganisms 2023; 11 (5): 1294. doi: 10.3390/microorganisms11051294.
8. Meselson M, Guillemin J, Hugh-Jones M, Langmuir A, Popova I, Shelokov A, Yampolskaya O. The Sverdlovsk anthrax outbreak of 1979. Science 1994; 266 (5188): 1202-1208. doi: 10.1126/science.7973702.
9. Jernigan JA, Stephens DS, Ashford DA, Omenaca C, Topiel MS, Galbraith M, Tapper M, Fisk TL, Zaki S, Popovic T, Meyer RF, Quinn CP, Harper SA, Fridkin SK, Sejvar JJ, Shepard CW, McConnell M, Guarner J, Shieh WJ, Malecki JM, Gerberding JL, Hughes JM, Perkins BA; Anthrax Bioterrorism Investigation Team. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis 2001; 7 (6): 933-944. doi: 10.3201/eid0706.010604.
10. Centers for Disease Control and Prevention (CDC). https://emergency.cdc.gov/agent/agentlist-category.asp
11. Georgopoulos AP, James LM. Anthrax vaccines in the 21st century. Vaccines (Basel) 2024; 12 (2): 159. doi: 10.3390/vaccines12020159.
12. U.S. Food and Drug Administration (FDA). https://www.fda.gov/vaccines-blood-biologics/vaccines/biothrax
13. Paul-Ehrlich-Institut (PEI). https://www.pei.de/EN/medicinal-products/vaccines-human/anthrax/anthrax-node.html
14. Berger T, Kassirer M, Aran AA. Injectional anthrax – new presentation of an old disease. Euro Surveill 2014; 19 (32): 20877. doi: 10.2807/1560-7917.es2014.19.32.20877.
15. Zasada AA. Injectional anthrax in human: A new face of the old disease. Adv Clin Exp Med 2018; 27 (4): 553-558. doi: 10.17219/acem/68380.
16. Hanczaruk M, Reischl U, Holzmann T, Frangoulidis D, Wagner DM, Keim PS, Antwerpen MH, Meyer H, Grass G. Injectional anthrax in heroin users, Europe, 2000-2012. Emerg Infect Dis 2014; 20 (2): 322-323. doi: 10.3201/eid2002.120921.
17. Radun D, Bernard H, Altmann M, Schöneberg I, Bochat V, van Treeck U, Rippe RM, Grunow R, Elschner M, Biederbick W, Krause G. Preliminary case report of fatal anthrax in an injecting drug user in North-Rhine-Westphalia, Germany, December 2009. Euro Surveill 2010; 15 (2): 19464. doi: 10.2807/ese.15.02.19464-en.
18. Holzmann T, Frangoulidis D, Simon M, Noll P, Schmoldt S, Hanczaruk M, Grass G, Pregler M, Sing A, Hörmansdorfer S, Bernard H, Grunow R, Zimmermann R, Schneider-Brachert W, Gessner A, Reischl U. Fatal anthrax infection in a heroin user from southern Germany, June 2012. Euro Surveill 2012; 17 (26): 20204. doi: 10.2807/ese.17.26.20204-en.
19. Railean V, Sobolewski J, Jaśkowski JM. Anthrax in one health in Southern and Southeastern Europe – the effect of climate change? Vet Res Commun 2024; 48 (2): 623-632. doi: 10.1007/s11259-023-10238-3.
20. Otieno FT, Gachohi J, Gikuma-Njuru P, Kariuki P, Oyas H, Canfield SA, Bett B, Njenga MK, Blackburn JK. Modeling the potential future distribution of anthrax outbreaks under multiple climate change scenarios for Kenya. Int J Environ Res Public Health 2021; 18 (8): 4176. doi: 10.3390/ijerph18084176.
21. Walsh MG, de Smalen AW, Mor SM. Climatic influence on anthrax suitability in warming northern latitudes. Sci Rep 2018; 8 (1): 9269. doi: 10.1038/s41598-018-27604-w.
